Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

1.

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.

Follo MY, Pellagatti A, Armstrong RN, Ratti S, Mongiorgi S, De Fanti S, Bochicchio MT, Russo D, Gobbi M, Miglino M, Parisi S, Martinelli G, Cavo M, Luiselli D, McCubrey JA, Suh PG, Manzoli L, Boultwood J, Finelli C, Cocco L.

Leukemia. 2019 Feb 20. doi: 10.1038/s41375-019-0416-x. [Epub ahead of print]

PMID:
30787430
2.

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib.

Nannini M, Tarantino G, Indio V, Ravegnini G, Astolfi A, Urbini M, De Leo A, Santini D, Ceccarelli C, Gruppioni E, Altimari A, Castellucci P, Fanti S, Di Scioscio V, Saponara M, Gatto L, Pession A, Martelli PL, Casadio R, Pantaleo MA.

Sci Rep. 2019 Feb 18;9(1):2172. doi: 10.1038/s41598-018-38028-x.

3.

The genetic legacy of the Yaghnobis: A witness of an ancient Eurasian ancestry in the historically reshuffled central Asian gene pool.

Cilli E, Sarno S, Gnecchi Ruscone GA, Serventi P, De Fanti S, Delaini P, Ognibene P, Basello GP, Ravegnini G, Angelini S, Ferri G, Gentilini D, Di Blasio AM, Pelotti S, Pettener D, Sazzini M, Panaino A, Luiselli D, Gruppioni G.

Am J Phys Anthropol. 2019 Jan 29. doi: 10.1002/ajpa.23789. [Epub ahead of print]

PMID:
30693949
4.

A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension.

Barozzi C, Galletti M, Tomasi L, De Fanti S, Palazzini M, Manes A, Sazzini M, Galiè N.

Sci Rep. 2019 Jan 24;9(1):753. doi: 10.1038/s41598-018-37277-0.

5.

68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma.

Tabacchi E, Campana D, Brighi N, Fanti S, Ambrosini V.

Clin Nucl Med. 2019 Mar;44(3):238-239. doi: 10.1097/RLU.0000000000002426.

PMID:
30672751
6.

Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors.

Serenari M, Pettinato C, Bonatti C, Zanoni L, Odaldi F, Cucchetti A, Ravaioli M, Fanti S, Pinna AD, Cescon M.

Transplant Proc. 2019 Jan - Feb;51(1):167-170. doi: 10.1016/j.transproceed.2018.04.087. Epub 2018 Jun 30.

PMID:
30655158
7.

Vertebral Fractures of Unknown Origin: Role of Computed Tomography-Guided Biopsy.

Spinnato P, Bazzocchi A, Facchini G, Filonzi G, Nanni C, Rambaldi I, Rimondi E, Fanti S, Albisinni U.

Int J Spine Surg. 2018 Dec 21;12(6):673-679. doi: 10.14444/5084. eCollection 2018 Dec.

8.

Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis.

Polverari G, Ceci F, Calderoni L, Cervati V, Farolfi A, Castellucci P, Fanti S.

Clin Genitourin Cancer. 2018 Dec 4. pii: S1558-7673(18)30779-1. doi: 10.1016/j.clgc.2018.11.020. [Epub ahead of print] No abstract available.

PMID:
30587404
9.

Single Subcutaneous Prostate Cancer Metastasis Detected by 68Ga-PSMA PET/CT During Early Biochemical Relapse: A Case Report.

Calderoni L, Matei Deliu V, Farolfi A, Lambertini A, Renne G, Lorenzini D, Cervati V, Lodi F, Castellucci P, Fanti S.

Clin Genitourin Cancer. 2018 Nov 26. pii: S1558-7673(18)30722-5. doi: 10.1016/j.clgc.2018.11.012. [Epub ahead of print] No abstract available.

PMID:
30558835
10.

Consensus on molecular imaging and theranostics in prostate cancer.

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG.

Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1. Review.

PMID:
30507436
11.

Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer.

Lam TBL, MacLennan S, Plass K, Willemse PM, Mason MD, Cornford P, Donaldson J, Davis NF, Dell'Oglio P, Fankhauser C, Grivas N, Ingels A, Lardas M, Liew M, Pang KH, Paterson C, Omar MI, Zattoni F, Buddingh KT, Van den Broeck T, Cumberbatch MG, Fossati N, Gross T, Moris L, Schoots IG, van den Bergh RCN, Briers E, Fanti S, De Santis M, Gillessen S, Grummet JP, Henry AM, van der Poel HG, van der Kwast TH, Rouvière O, Tilki D, Wiegel T, N'Dow J, Van Poppel H, Mottet N.

Eur Urol. 2018 Nov 22. pii: S0302-2838(18)30866-2. doi: 10.1016/j.eururo.2018.11.009. [Epub ahead of print] No abstract available.

PMID:
30473433
12.

Radioguided surgery with β radiation: a novel application with Ga68.

Collamati F, Bocci V, Castellucci P, De Simoni M, Fanti S, Faccini R, Giordano A, Maccora D, Mancini-Terracciano C, Marafini M, Mirabelli R, Morganti S, Schiavina R, Scotognella T, Traini G, Solfaroli Camillocci E.

Sci Rep. 2018 Nov 1;8(1):16171. doi: 10.1038/s41598-018-34626-x.

13.

First evidence of association between past environmental exposure to dioxin and DNA methylation of CYP1A1 and IGF2 genes in present day Vietnamese population.

Giuliani C, Biggs D, Nguyen TT, Marasco E, De Fanti S, Garagnani P, Le Phan MT, Nguyen VN, Luiselli D, Romeo G.

Environ Pollut. 2018 Nov;242(Pt A):976-985. doi: 10.1016/j.envpol.2018.07.015. Epub 2018 Jul 17.

PMID:
30373043
14.

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):31-39. doi: 10.1007/s00259-018-4189-7. Epub 2018 Oct 22.

PMID:
30350010
15.

18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature.

Saponara M, Ambrosini V, Nannini M, Gatto L, Astolfi A, Urbini M, Indio V, Fanti S, Pantaleo MA.

Ther Adv Med Oncol. 2018 Aug 30;10:1758835918793569. doi: 10.1177/1758835918793569. eCollection 2018.

16.

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N.

Eur Urol. 2018 Oct 17. pii: S0302-2838(18)30752-8. doi: 10.1016/j.eururo.2018.10.011. [Epub ahead of print] Review.

PMID:
30342843
17.

Evidence of Polygenic Adaptation to High Altitude from Tibetan and Sherpa Genomes.

Gnecchi-Ruscone GA, Abondio P, De Fanti S, Sarno S, Sherpa MG, Sherpa PT, Marinelli G, Natali L, Di Marcello M, Peluzzi D, Luiselli D, Pettener D, Sazzini M.

Genome Biol Evol. 2018 Nov 1;10(11):2919-2930. doi: 10.1093/gbe/evy233.

18.

Correction to: Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine.

Farolfi A, Ghedini P, Fanti S.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):266. doi: 10.1007/s00259-018-4190-1.

PMID:
30315321
19.

FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

Aide N, Hicks RJ, Le Tourneau C, Lheureux S, Fanti S, Lopci E.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):238-250. doi: 10.1007/s00259-018-4171-4. Epub 2018 Oct 5. Review.

20.

Fluoride PET/CT in Metastatic Benign Pulmonary Calcification.

Lima GM, Bonfiglioli R, Matti A, Fanti S.

Nuklearmedizin. 2018 Sep;57(5):N50-N51. doi: 10.3413/Nukmed-0968-18-03. Epub 2018 Sep 28. No abstract available.

PMID:
30267396
21.

Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine.

Farolfi A, Ghedini P, Fanti S.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):217-223. doi: 10.1007/s00259-018-4169-y. Epub 2018 Sep 28. Review. Erratum in: Eur J Nucl Med Mol Imaging. 2018 Oct 12;:.

PMID:
30267115
22.

State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.

Schiavina R, Chessa F, Borghesi M, Gaudiano C, Bianchi L, Corcioni B, Castellucci P, Ceci F, Ceravolo I, Barchetti G, Del Monte M, Campa R, Catalano C, Panebianco V, Nanni C, Fanti S, Minervini A, Porreca A, Brunocilla E.

Int J Urol. 2019 Jan;26(1):18-30. doi: 10.1111/iju.13797. Epub 2018 Sep 20. Review.

PMID:
30238516
23.

Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.

Diemberger I, Bonfiglioli R, Martignani C, Graziosi M, Biffi M, Lorenzetti S, Ziacchi M, Nanni C, Fanti S, Boriani G.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):194-205. doi: 10.1007/s00259-018-4142-9. Epub 2018 Sep 8.

PMID:
30196365
24.

Delivering PET imaging results to cancer patients: steps for handling ethical issues.

Gonzalez S, Guedj E, Fanti S, Lalumera E, Le Coz P, Taïeb D.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2240-2241. doi: 10.1007/s00259-018-4124-y. Epub 2018 Aug 14. No abstract available.

PMID:
30109400
25.

Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Lima GM, Matti A, Vara G, Dondi G, Naselli N, De Crescenzo EM, Morganti AG, Perrone AM, De Iaco P, Nanni C, Fanti S.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2139-2146. doi: 10.1007/s00259-018-4077-1. Epub 2018 Aug 2.

26.

Imaging of Prostate Cancer Using 11C-Choline PET/Computed Tomography.

Castellucci P, Ceci F, Fanti S.

Urol Clin North Am. 2018 Aug;45(3):481-487. doi: 10.1016/j.ucl.2018.03.007. Review.

PMID:
30031467
27.

Considerations on 18FDG PET/CT and sentinel lymph node biopsy in AJCC stages I and II of melanoma.

Veronesi G, Ravaioli GM, Lambertini M, Zannetti G, Diodato S, Gardini A, Patrizi A, Fanti S, Dika E.

G Ital Dermatol Venereol. 2018 Jul 10. doi: 10.23736/S0392-0488.18.06108-4. [Epub ahead of print] No abstract available.

PMID:
29998716
28.

68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.

Farolfi A, Ceci F, Castellucci P, Graziani T, Siepe G, Lambertini A, Schiavina R, Lodi F, Morganti AG, Fanti S.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19. doi: 10.1007/s00259-018-4066-4. Epub 2018 Jun 15.

PMID:
29905907
29.

Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer.

Schiavina R, Bianchi L, Mineo Bianchi F, Borghesi M, Pultrone CV, Dababneh H, Castellucci P, Ceci F, Nanni C, Gaudiano C, Fiorentino M, Porreca A, Chessa F, Minervini A, Fanti S, Brunocilla E.

Clin Genitourin Cancer. 2018 Aug;16(4):305-312.e1. doi: 10.1016/j.clgc.2018.05.010. Epub 2018 May 30.

PMID:
29859737
30.

Rapidly growing pulmonary ground-glass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT.

Dalpiaz G, Asioli S, Fanti S, Rea G, Marchiori E.

J Bras Pneumol. 2018 Apr;44(2):171-172. doi: 10.1590/s1806-37562017000000298. English, Portuguese. No abstract available.

31.

Low dose radiation 18F-fluoride PET/CT in the assessment of Unilateral Condylar Hyperplasia of the mandible: preliminary results of a single centre experience.

Lima GM, Diodato S, Costabile E, Cicoria G, Civollani S, Marchetti C, Guidalotti PL, Pettinato C, Nanni C, Fanti S.

Eur J Hybrid Imaging. 2018;2(1):7. doi: 10.1186/s41824-018-0025-3. Epub 2018 Apr 9.

32.

Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial.

Spadafora M, Pace L, Evangelista L, Mansi L, Del Prete F, Saladini G, Miletto P, Fanti S, Del Vecchio S, Guerra L, Pepe G, Peluso G, Nicolai E, Storto G, Ferdeghini M, Giordano A, Farsad M, Schillaci O, Gridelli C, Cuocolo A.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1908-1914. doi: 10.1007/s00259-018-4043-y. Epub 2018 May 5.

PMID:
29730697
33.

Highlights of the 30th Annual Congress of the EANM, Vienna 2017: "Yes we can - make nuclear medicine great again".

Fanti S, Bonfiglioli R, Decristoforo C.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1781-1794. doi: 10.1007/s00259-018-4029-9. Epub 2018 May 3. Review.

34.

223Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience.

Boni G, Mazzarri S, Cianci C, Galli L, Farnesi A, Borsatti E, Bortolus R, Fratino L, Gobitti C, Lamaj E, Ghedini P, Rizzini EL, Massari F, Dionisi V, Fanti S, Volterrani D, Monari F.

Tumori. 2018 Mar-Apr;104(2):128-136. doi: 10.1177/0300891618765571. Epub 2018 Apr 18.

PMID:
29714668
35.

Incidental Detection of Basaloid Thymic Carcinoma With 68Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate Cancer.

Farolfi A, Ceci F, Graziani T, Lambertini A, Cervati V, Basilico GL, Biraghi T, Briganti A, Castellucci P, Fanti S.

Clin Genitourin Cancer. 2018 Jun;16(3):e497-e499. doi: 10.1016/j.clgc.2018.02.019. Epub 2018 Feb 23. No abstract available.

PMID:
29550202
36.

Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.

Ceci F, Castellucci P, Fanti S.

Q J Nucl Med Mol Imaging. 2019 Mar;63(1):7-18. doi: 10.23736/S1824-4785.18.03059-5. Epub 2018 Mar 8.

PMID:
29521482
37.

Cholescintigraphic patterns in a IBS patient with postprandial diarrhea.

Bortolotti M, Zanoni L, Levorato M, Fanti S.

Dig Liver Dis. 2018 Jul;50(7):720-721. doi: 10.1016/j.dld.2018.01.139. Epub 2018 Feb 5. No abstract available.

PMID:
29456096
38.

Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.

Haroon A, Afaq A, Nuthakki S, Freeman A, Biassoni L, Fanti S, Beheshti M, Jan H, Vinjamuri S, Emberton M, Bomanji J.

Nucl Med Commun. 2018 Mar;39(3):196-204. doi: 10.1097/MNM.0000000000000797.

PMID:
29384832
39.

Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.

Cima S, Perrone AM, Castellucci P, Macchia G, Buwenge M, Cammelli S, Cilla S, Ferioli M, Ferrandina G, Galuppi A, Salizzoni E, Rubino D, Fanti S, De Iaco P, Morganti AG.

Int J Gynecol Cancer. 2018 Mar;28(3):575-580. doi: 10.1097/IGC.0000000000001207.

PMID:
29372911
40.

A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer.

Zanoni L, Bossert I, Matti A, Schiavina R, Pultrone C, Fanti S, Nanni C.

Future Oncol. 2018 May;14(11):1101-1115. doi: 10.2217/fon-2017-0446. Epub 2018 Jan 23. Review.

PMID:
29359581
41.

Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.

Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L.

Abdom Radiol (NY). 2018 Sep;43(9):2391-2399. doi: 10.1007/s00261-017-1443-6.

PMID:
29302738
42.

Current status of theranostics in prostate cancer.

Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):471-495. doi: 10.1007/s00259-017-3882-2. Epub 2017 Dec 28. Review.

43.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Nanni C, Versari A, Chauvie S, Bertone E, Bianchi A, Rensi M, Bellò M, Gallamini A, Patriarca F, Gay F, Gamberi B, Ghedini P, Cavo M, Fanti S, Zamagni E.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

PMID:
29270787
44.

Three Reportedly Unrelated Families With Liddle Syndrome Inherited From a Common Ancestor.

Pagani L, Diekmann Y, Sazzini M, De Fanti S, Rondinelli M, Farnetti E, Casali B, Caretto A, Novara F, Zuffardi O, Garagnani P, Mantero F, Thomas MG, Luiselli D, Rossi E.

Hypertension. 2018 Feb;71(2):273-279. doi: 10.1161/HYPERTENSIONAHA.117.10491. Epub 2017 Dec 11.

45.

Iron Age Italic population genetics: the Piceni from Novilara (8th-7th century BC).

Serventi P, Panicucci C, Bodega R, De Fanti S, Sarno S, Fondevila Alvarez M, Brisighelli F, Trombetta B, Anagnostou P, Ferri G, Vazzana A, Delpino C, Gruppioni G, Luiselli D, Cilli E.

Ann Hum Biol. 2018 Feb;45(1):34-43. doi: 10.1080/03014460.2017.1414876.

PMID:
29216758
46.

FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond.

Matti A, Farolfi A, Frisoni T, Fanti S, Nanni C.

Clin Nucl Med. 2018 Feb;43(2):e48-e49. doi: 10.1097/RLU.0000000000001918.

PMID:
29215413
47.

18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study.

Farina E, Monari F, Castellucci P, Romani F, Repaci A, Farina A, Zanirato Rambaldi G, Frezza G, Mazzarotto R, Cammelli S, Tagliaferri L, Autorino R, Deodato F, Macchia G, Cilla S, Valentini V, Fanti S, Morganti AG.

J Thyroid Res. 2017;2017:9807543. doi: 10.1155/2017/9807543. Epub 2017 Oct 19.

48.

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.

Ghedini P, Bossert I, Zanoni L, Ceci F, Graziani T, Castellucci P, Ambrosini V, Massari F, Nobili E, Melotti B, Musto A, Zoboli S, Antunovic L, Kirienko M, Chiti A, Mosconi C, Ardizzoni A, Golfieri R, Fanti S, Nanni C.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):751-758. doi: 10.1007/s00259-017-3888-9. Epub 2017 Nov 30.

PMID:
29192364
49.

18F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art.

Farina E, Ferioli M, Castellucci P, Farina A, Zanirato Rambaldi G, Cilla S, Cammelli S, Fanti S, Morganti AG.

Anticancer Res. 2017 Dec;37(12):6523-6532. Review.

PMID:
29187426
50.

The genomic landscape of Nepalese Tibeto-Burmans reveals new insights into the recent peopling of Southern Himalayas.

Gnecchi-Ruscone GA, Jeong C, De Fanti S, Sarno S, Trancucci M, Gentilini D, Di Blasio AM, Sherpa MG, Sherpa PT, Marinelli G, Di Marcello M, Natali L, Peluzzi D, Pettener D, Di Rienzo A, Luiselli D, Sazzini M.

Sci Rep. 2017 Nov 14;7(1):15512. doi: 10.1038/s41598-017-15862-z.

Supplemental Content

Support Center